Skip to main content
. 2017 Nov;9(11):4607–4650. doi: 10.21037/jtd.2017.10.112

Table 9. Grading system for local adverse events in sublingual immunotherapy (SLIT) according to the World Allergy Organisation (279).

Symptom/sign
   Pruritus/swelling of mouth, tongue, or lip; throat irritation*, nausea, abdominal pain, vomiting, diarrhea, heartburn, or uvular edema
Grade 1: mild
   Not troublesome and no symptomatic treatment required and no discontinuation of SLIT because of local side effects
Grade 2: moderate
   Troublesome or requires symptomatic treatment and no discontinuation of SLIT because of local side effects
Grade 3: severe
   Grade 2 and SLIT discontinued because of local side effects
Unknown severity
   Treatment is discontinued, but there is no subjective, objective, or both description of severity from the patient/physician

Each local adverse event can be early (<30 min) or delayed. *, for example, itchy palate, burning or swelling of the throat.